Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection  Shiro Nagatani, MD, Yutaka Shimada,

Published byMartin Bennett Modified over 5 years ago

Similar presentations

Presentation on theme: "A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection  Shiro Nagatani, MD, Yutaka Shimada,"— Presentation transcript:

1 A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection  Shiro Nagatani, MD, Yutaka Shimada, MD, PhD, Masato Kondo, MD, Junichi Kaganoi, MD, PhD, Masato Maeda, MD, PhD, Go Watanabe, MD, PhD, Masayuki Imamura, MD, PhD  The Annals of Thoracic Surgery  Volume 80, Issue 5, Pages (November 2005) DOI: /j.athoracsur Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 The prospective study process. Group A patients underwent cervical lymph node (LN) dissection because they were diagnosed as having upper mediastinal LN metastasis by intraoperative diagnosis. Group B patients received cervical LN dissection with randomized selection. Group C patients did not receive cervical LN dissection with randomized selection. (ESCC = esophageal squamous cell carcinoma.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Results of intraoperative detection of thoracic paratracheal lymph node (LN) metastasis and metastatic status in cervical lymph nodes. Cervical LN metastasis was detected by conventional hematoxylin and eosin staining and real-time reverse transcription-polymerase chain reaction. Cervical LN recurrence was followed up by commonly used diagnostic techniques, such as computed tomography and ultrasonography. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier curves showing overall survival rate according to doing the neck dissection or not in 30 patients (log-rank test, p = 0.116). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection  Shiro Nagatani, MD, Yutaka Shimada,"

Similar presentations

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Squamous Cell Carcinoma of the Pericardium Found During Coronary Bypass Surgery of Possible Cutaneous Origin  Alan P. Kypson, MD, Curtis A. Anderson,

Squamous Cell Carcinoma of the Pericardium Found During Coronary Bypass Surgery of Possible Cutaneous Origin  Alan P. Kypson, MD, Curtis A. Anderson,
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Endobronchial Ultrasonography for Positron Emission Tomography and Computed Tomography–Negative Lymph Node Staging in Non-Small Cell Lung Cancer  Masato.

Endobronchial Ultrasonography for Positron Emission Tomography and Computed Tomography–Negative Lymph Node Staging in Non-Small Cell Lung Cancer  Masato.
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
A Strategy for Supraclavicular Lymph Node Dissection Using Recurrent Laryngeal Nerve Lymph Node Status in Thoracic Esophageal Squamous Cell Carcinoma 

A Strategy for Supraclavicular Lymph Node Dissection Using Recurrent Laryngeal Nerve Lymph Node Status in Thoracic Esophageal Squamous Cell Carcinoma 
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,

Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,
Long-Term Effectiveness of Total Arch Replacement for Type A Aortic Dissection  Yoshie Ochiai, MD, Yutaka Imoto, MD, Masato Sakamoto, MD, Yasutaka Ueno,

Long-Term Effectiveness of Total Arch Replacement for Type A Aortic Dissection  Yoshie Ochiai, MD, Yutaka Imoto, MD, Masato Sakamoto, MD, Yasutaka Ueno,
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Similar presentations

Ads by Google